University of North Carolina, Chapel Hill: Alcoholism trials
The registry lists 16 Alcoholism studies with University of North Carolina, Chapel Hill as lead sponsor. 0 are open to participants now and 8 have results posted.
Phase 1 1Phase 2 8Phase 3 2Phase 4 1No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Pilot Study on Training Emerging Adults Skills in Navigating CollegeCompletedNCT05560425Not applicableResults posted
- Semaglutide for Alcohol Use DisorderCompletedNCT05520775Phase 2Results posted
- Buproprion for Binge DrinkingCompletedNCT03169244Phase 2Results posted
- Oxytocin Treatment of Alcohol DependenceCompletedNCT02275611Phase 2Results posted
- Oxytocin Treatment of Alcohol DependenceCompletedNCT02251912Phase 2Results posted
- Efficacy and Safety of High Dose Baclofen for Alcohol DependenceCompletedNCT01980706Phase 2Results posted
- Sweet Preference and Alcohol CravingCompletedNCT01296646Phase 2Results posted
- Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine ClinicCompletedNCT00381043Phase 4Results posted
- Ultrabrief Behavioral Activation for Reducing Alcohol UseCompletedNCT05086172Not applicable
- STUN (STop UNhealthy) Alcohol Use Now! Implementing Evidence-Based Services for Unhealthy Alcohol Use in Primary CareCompletedNCT04317989Not applicable
- Oxytocin Treatment for Alcohol Use DisordersWithdrawnNCT03636555Phase 2
- Understanding Longitudinal Clinical Outcomes and Post-release Retention in Care Among HIV-infected Prisoners in Lusaka, ZambiaCompletedNCT02905162
- Study of an Emergency Department-based Intervention to Reduce Alcohol Misuse in Older AdultsCompletedNCT02236494Not applicable
- Efficacy and Tolerability of Baclofen for Alcohol DependenceCompletedNCT00877734Phase 2/3
- Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study.CompletedNCT00614328Phase 1
- COMBINE (Acamprosate/Naltrexone)CompletedNCT00006206Phase 3